Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Taxes (2020 - 2022)

Legend Biotech (LEGN) posted Change in Taxes of $3.7 million for Q4 2022, up 565.89% on a QoQ basis from $557000.0 in Q4 2021, and up 565.89% year-over-year from $557000.0 in Q4 2021.

Legend Biotech (LEGN) has 3 years of Change in Taxes data on file, last reported at $3.7 million in Q4 2022.

  • In Q4 2022, Change in Taxes rose 565.89% year-over-year to $3.7 million; the TTM figure through Sep 2023 stood at $4.3 million (down 46.33% YoY), while the FY2022 annual figure was $3.7 million, up 565.89% from the prior year.
  • Change in Taxes improved to $3.7 million in Q4 2022, from $557000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $7.4 million in Q4 2020 and bottomed at $508000.0 in Q3 2020.
  • A 3-year average of $3.2 million and a median of $3.7 million in 2020 frame the typical range for Change in Taxes.
  • Annual changes were most pronounced in 2021 — Change in Taxes slumped 92.46% — and 2022, when it surged 565.89%.
  • Year by year, Change in Taxes stood at $7.4 million in 2020, then slumped by 92.46% to $557000.0 in 2021, then surged by 565.89% to $3.7 million in 2022.
  • The last three Change in Taxes figures came in at $3.7 million (Q4 2022), $557000.0 (Q4 2021), and $7.4 million (Q4 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 3.71 Mn
Dec 31, 2022 3.71 Mn
Dec 31, 2021 557,000.00
Dec 31, 2021 557,000.00
Dec 31, 2020 7.39 Mn
Dec 31, 2020 7.39 Mn
Sep 30, 2020 508,000.00
Sep 30, 2020 508,000.00
Mar 31, 2020 3.71 Mn
Mar 31, 2020 3.71 Mn